Goumenos, Stavros
Savvidou, Olga
Renieris, George
Gkavogianni, Theologia
Papagelopoulos, Panayiotis J.
Giamarellos-Bourboulis, Evangelos J.
Funding for this research was provided by:
Hellenic Institute for the Study of Sepsis
Article History
Received: 12 September 2019
Accepted: 31 December 2019
First Online: 28 January 2020
Competing interests
: E.J. Giamarellos-Bourboulis has received honoraria (paid to the University of Athens) from AbbVie USA, Abbott CH, Biotest Germany, Brahms GmbH, InflaRx GmbH, MSD Greece and XBiotech Inc. He has received independent educational grants from AbbVie, Abbott, Astellas Pharma, AxisShield, bioMérieux Inc, InflaRx GmbH, the Medicines Company and XBiotech Inc. He has received funding from the FrameWork 7 program HemoSpec and from the Horizon2020 Marie-Curie project European Sepsis Academy (granted to the National and Kapodistrian University of Athens). The other authors do not have any competing interest to declare.